Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-TM-601 in recurrent high-grade glioma
NCT00040573Phase 2Completed
- Sponsor
- TransMolecular
- Start
- Jun 2002
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of 131i-tm601 in glioma, sponsored by TransMolecular. Started Jun 2002; status: completed.
02
Drugs
131i-tm601
03
Conditions
glioma
Beyond the preview
Go deeper on NCT00040573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040573.